cyc 202 has been researched along with methylprednisolone in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (methylprednisolone) | Trials (methylprednisolone) | Recent Studies (post-2010) (methylprednisolone) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 20,247 | 2,602 | 5,317 |
| Protein | Taxonomy | cyc 202 (IC50) | methylprednisolone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.011 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Benigni, A; Casiraghi, F; Cavinato, RA; Conti, S; Corna, D; Remuzzi, G; Rottoli, D; Zoja, C | 1 |
3 other study(ies) available for cyc 202 and methylprednisolone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
Topics: Animals; Anti-Inflammatory Agents; Autoimmunity; B-Lymphocytes; Cell Proliferation; Cyclin-Dependent Kinases; Disease Models, Animal; Drug Therapy, Combination; Female; Glomerulonephritis; Longevity; Lupus Erythematosus, Systemic; Methylprednisolone; Mice; Mice, Inbred NZB; Mice, Inbred Strains; Protein Kinase Inhibitors; Proteinuria; Purines; Roscovitine; T-Lymphocytes | 2007 |